Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Chymotrypsin parenteral and ophthalmic II SEP / 98
Ciclopirox or its saltsPDL I DEC / 13
Cidofovir or its salts or its derivativesPDL I MAY / 18
Cilastatin or its saltsPDL I DEC / 13
Cilazapril or its salts or derivativesPDL I DEC / 13
Cimetidine or its saltsPDL

for veterinary use

I DEC / 13
Cimetidine or its salts.PDL

except when sold in concentrations of 200 milligrams or less per oral dosage unit and indicated for the treatment of heartburn

I DEC / 13
Cimetidine or its salts..

when sold in concentrations of 100 mg or less per dosage unit and indicated for the treatment of heartburn

III DEC / 13
Cinacalcet or its saltsPDL I DEC / 13
Cinchocaine (dibucaine) and its salts for ophthalmic or parenteral use II SEP / 98
Cinchophene or its saltsPDL I DEC / 13
Cinnamedrine U
CinoxacinPDL I DEC / 13
Ciprofloxacin or its saltsPDL I DEC / 13
Cisapride or its saltsPDL I SEP / 98
Cisatracurium besilatePDL I DEC / 13
CisplatinPDL I DEC / 13
Citalopram or its saltsPDL I DEC / 13
Cladribine or its salts or derivativesPDL I DEC / 13
Clemastine and its salts III SEP / 98
Clenbuterol or its saltsPDL I DEC / 13
Clevidipine or its saltsPDL I DEC / 13
Clidinium and its salts II SEP / 98
Clobazam and its saltsTS I SEP / 98
Clobetasone butyrate when sold in a concentration of 0.05% clobetasone butyrate in cream preparations for topical use on the skin II OCT / 06
Clodronic acid or its saltsPDL I DEC / 13
ClofarabinePDL I DEC / 13
ClofibratePDL I DEC / 13
Clomiphene or its saltsPDL I DEC / 13
Clomipramine or its saltsPDL I DEC / 13
Clonazepam and its saltsTS I SEP / 98
Clonidine or its saltsPDL I DEC / 13
ClonitazeneN I JUN / 02
Clopidogrel or its saltsPDL I DEC / 13
ClorazepateTS I JUN / 02
Clorazepic acid or its saltsPDL I DEC / 13
Closantel or its saltsPDL

for veterinary use, including but not limited to closantel sodium

I AUG / 16
ClostebolC3 I JUN / 02
Clotiazepam and any salt thereofTS I JUN / 02
Clotrimazole and its salts.. for human use in preparations for topical use U DEC / 13
Clotrimazole or its saltsPDL

for human use, except in preparations for topical or vaginal use

I DEC / 13
Clotrimazole or its salts.

for human use in preparations for intra-vaginal use

III DEC / 13
CloxazolamTS I JUN / 02
Clozapine or its saltsPDL I DEC / 13
Coal tar in concentrations of more than 10% II SEP / 98
Coal tar. in concentrations up to and including 10% U
Cobicistat or its saltsPDL I DEC / 18
Cobimetinib or its saltsPDL I AUG / 16
Coca leavesN I JUN / 02
Cocaine (benzoylmethylecgonine)N Subject to Section 2 (2) of the Narcotic Control Regulations (NCR) and Section J of the Food and Drug Regulations (FDR) as of 23 October 2013. I JUN / 02
CodeineN I JUN / 02
Codeine and its salts in preparations exempted from the Regulations to the Controlled Drugs and Substances Act II SEP / 98
CodoximeN I JUN / 02
ColchicinePDL I DEC / 13
Colesevelam or its saltsPDL

including but not limited to colesevelam hydrochloride

I DEC / 13
Colestipol or its saltsPDL I DEC / 13
Colfosceril or its derivativesPDL I DEC / 13
Colistin or its salt or derivativesPDL

including but not limited to colistimethate

I DEC / 13
CollagenasePDL

when recommend for the debridement of severe burns and skin ulcers

I DEC / 13
Copper chloride (cupric chloride) in injectable form for parenteral nutrition I JAN / 03
Copper sulfate in injectable form for parenteral nutrition I JAN / 03
CrisaborolePDL I JUL / 18
Crizotinib or its salts or derivativesPDL I DEC / 13
Cromoglicic (cromoglycic) acid or its saltsPDL

except sodium cromoglicate (cromoglycate) in solutions for ophthalmic or nasal use in concentrations of 2% or less [*see sodium cromoglicate (cromoglycate)]

I DEC / 13
Crotamiton II SEP / 98
Cyclandelate II SEP / 98
Cyclazocine and its salts II SEP / 98
CyclizinePDL

for human use

I DEC / 13
CyclobarbitalC2 I JUN / 02
Cyclobenzaprine or its saltsPDL I DEC / 13
Cyclomethacaine and its salts for ophthalmic or parenteral use II SEP / 98
CyclopalC2 I JUN / 02
Cyclopentamine and its salts II SEP / 98
Cyclopentolate or its salts except in products for ophthalmic or parenteral use II SEP / 98
Cyclopentolate or its saltsPDL

in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada

I DEC / 13
CyclophosphamidePDL I DEC / 13
CycloserinePDL I DEC / 13
CyclosporinePDL

including but not limited to ciclosporin

I DEC / 13
Cyproheptadine and its salts II SEP / 98
Cyproterone acetatePDL

including but not limited to cyproterone acetate

I DEC / 13
Cysteamine (Mercaptamine) or its saltsPDL I AUG / 17
Cytarabine or its saltsPDL I DEC / 13
Cytomegalovirus immune globulins I FEB / 02

183 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled